Cargando…

High Mobility Group Box 1 Influences HSV1716 Spread and Acts as an Adjuvant to Chemotherapy

High Mobility Group Box 1 (HMGB1) is a multifunctional protein that plays various roles in the processes of inflammation, cancer, and other diseases. Many reports document abundant HMGB1 release following infection with oncolytic viruses (OVs). Further, other groups including previous reports from o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sprague, Leslee, Lee, Joel M., Hutzen, Brian J., Wang, Pin-Yi, Chen, Chun-Yu, Conner, Joe, Braidwood, Lynne, Cassady, Kevin A., Cripe, Timothy P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869525/ https://www.ncbi.nlm.nih.gov/pubmed/29543735 http://dx.doi.org/10.3390/v10030132

Ejemplares similares

Potent efficacy signals from systemically administered oncolytic herpes simplex virus (HSV1716) in hepatocellular carcinoma xenograft models
por: Braidwood, Lynne, et al.
Publicado: (2014)

Inconsistencies in Modeling the Efficacy of the Oncolytic Virus HSV1716 Reveal Potential Predictive Biomarkers for Tolerability
por: Howard, Faith, et al.
Publicado: (2022)

HSV1716 Prevents Myeloma Cell Regrowth When Combined with Bortezomib In Vitro and Significantly Reduces Systemic Tumor Growth in Mouse Models
por: Tazzyman, Simon, et al.
Publicado: (2023)

Comparison of infectivity and spread between HSV-1 and HSV-2 based oncolytic viruses on tumor cells with different receptor expression profiles
por: Fu, Xinping, et al.
Publicado: (2018)

TGF-β Inhibition Improves Oncolytic Herpes Viroimmunotherapy in Murine Models of Rhabdomyosarcoma
por: Hutzen, Brian, et al.
Publicado: (2017)

Imperial Spain 1469-1716 /
por: Elliott, John Huxtable
Publicado: (1963)

Westminster Hospital, 1716–1966
por: Gaskell, E.
Publicado: (1968)

STING Restricts oHSV Replication and Spread in Resistant MPNSTs but Is Dispensable for Basal IFN-Stimulated Gene Upregulation
por: Lee, Joel M., et al.
Publicado: (2019)

Cooperation of Oncolytic Herpes Virotherapy and PD-1 Blockade in Murine Rhabdomyosarcoma Models
por: Chen, Chun-Yu, et al.
Publicado: (2017)

Immune responses following intrapleural administration of oncolytic SEPREHVIR in patients with malignant pleural mesothelioma
por: Learmonth, Kirsty, et al.
Publicado: (2015)

Engelbert Kaempfer 1651–1716: a biography
por: Harrison, Mark
Publicado: (1999)

Oncolytic herpes viruses, chemotherapeutics, and other cancer drugs
por: Braidwood, Lynne, et al.
Publicado: (2013)

Immunotherapies for pediatric cancer: current landscape and future perspectives
por: Hutzen, Brian, et al.
Publicado: (2019)

The Diary of Richard Kay (1716–51), a Lancashire Doctor
por: Gaskell, E.
Publicado: (1970)

Toward structural mechanics through wooden bridges in France (1716-1841)
por: Tardini, Chiara
Publicado: (2014)

1716. Results of the Respiratory Protection Effectiveness Clinical Trial (ResPECT)
por: Radonovich, Lewis, et al.
Publicado: (2018)

Expression of HSV-1 Receptors in EBV-Associated Lymphoproliferative Disease Determines Susceptibility to Oncolytic HSV
por: Wang, Pin-Yi, et al.
Publicado: (2012)

P1716: REGULAR HOSPITAL VISITS IMPROVE THE PROGNOSIS OF MULTIPLE MYELOMA PATIENTS
por: Li, X., et al.
Publicado: (2022)

Immunotherapeutic Challenges for Pediatric Cancers
por: Hutzen, Brian, et al.
Publicado: (2019)

Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapy
por: Friedman, Gregory K., et al.
Publicado: (2013)

Aurora A kinase inhibition enhances oncolytic herpes virotherapy through cytotoxic synergy and innate cellular immune modulation
por: Currier, Mark A., et al.
Publicado: (2017)

The quest for effective immunotherapies against malignant peripheral nerve sheath tumors: Is there hope?
por: Paudel, Siddhi N., et al.
Publicado: (2023)

1716. Baseline Serum C-Reactive Protein Level Predicts Mortality in Cryptococcal Meningitis
por: Chesdachai, Supavit, et al.
Publicado: (2019)

Human lactoferrin but not lysozyme neutralizes HSV-1 and inhibits HSV-1 replication and cell-to-cell spread
por: Välimaa, Hannamari, et al.
Publicado: (2009)

Spontaneous and Engineered Compensatory HSV Mutants that Counteract the Host Antiviral PKR Response
por: Shah, Amish C., et al.
Publicado: (2009)

Myelolytic Treatments Enhance Oncolytic Herpes Virotherapy in Models of Ewing Sarcoma by Modulating the Immune Microenvironment
por: Denton, Nicholas L., et al.
Publicado: (2018)

LAT Region Factors Mediating Differential Neuronal Tropism of HSV-1 and HSV-2 Do Not Act in Trans
por: Bertke, Andrea S., et al.
Publicado: (2012)

Optimization of Fungal Enzyme Production by Trichoderma harzianum KUC1716 through Surfactant-Induced Morphological Changes
por: Lee, Hanbyul, et al.
Publicado: (2017)

Kin and birth order effects on male child mortality: three East Asian populations, 1716–1945(,)
por: Dong, Hao, et al.
Publicado: (2017)

Oncolytic virus and PD-1/PD-L1 blockade combination therapy
por: Chen, Chun-Yu, et al.
Publicado: (2018)

Re-arthrodesis after primary ankle fusion: 134/1,716 cases from the Swedish Ankle Registry
por: Henricson, Anders, et al.
Publicado: (2018)

Systematic analysis of the necroptosis index in pan-cancer and classification in discriminating the prognosis and immunotherapy responses of 1716 glioma patients
por: Ma, Shuai, et al.
Publicado: (2023)

Two high-mobility group box domains act together to underwind and kink DNA
por: Sánchez-Giraldo, R., et al.
Publicado: (2015)

Oncolytic HSV virotherapy in murine sarcomas differentially triggers an antitumor T-cell response in the absence of virus permissivity
por: Leddon, Jennifer L, et al.
Publicado: (2015)

A New Approach to Assessing HSV-1 Recombination during Intercellular Spread
por: Law, Gabrielle A., et al.
Publicado: (2018)

HSV-1 hepatitis in an immunocompetent patient – Act before you know
por: Franco, Ana Rita, et al.
Publicado: (2022)

1716. In Vitro Drug-Drug Interaction Evaluation of Epetraborole, a Novel Bacterial Leucyl-tRNA Synthetase Inhibitor
por: Shafiee, Afshin, et al.
Publicado: (2022)

Novel Steroidal[17,16-d]pyrimidines Derived from Epiandrosterone and Androsterone: Synthesis, Characterization and Configuration-Activity Relationships
por: Yang, Fei, et al.
Publicado: (2023)

Migrasomes released by HSV-2-infected cells serve as a conveyance for virus spread
por: Liu, Yalan, et al.
Publicado: (2023)

IL-25 Enhances HSV-1 Replication by Inhibiting Filaggrin Expression, and Acts Synergistically with T(H)2 Cytokines to Enhance HSV-1 Replication
por: Kim, Byung Eui, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_e98649c4dgihdu93s51j1qisn3